Jonathan Winkler

2.1k total citations · 2 hit papers
19 papers, 1.5k citations indexed

About

Jonathan Winkler is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Jonathan Winkler has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Jonathan Winkler's work include Bacterial Genetics and Biotechnology (4 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jonathan Winkler is often cited by papers focused on Bacterial Genetics and Biotechnology (4 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jonathan Winkler collaborates with scholars based in United States, Australia and India. Jonathan Winkler's co-authors include James J. Collins, Catherine S. Spina, José Rubén Morones‐Ramírez, Mark P. Brynildsen, Graham C. Walker, Bryan W. Davies, Michael A. Kohanski, Lyle A. Simmons, Elizabeth Hohmann and Tanvi Dhere and has published in prestigious journals such as Science, Nature Biotechnology and Molecular Cell.

In The Last Decade

Jonathan Winkler

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria

2013 615 citations José Rubén Morones‐Ramírez, Jonathan Winkler et al. Science Translational Medicine profile →
Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production

2013 388 citations Mark P. Brynildsen, Jonathan Winkler et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Winkler United States	9	620	341	268	254	253	19	1.5k
Heleen Van Acker Belgium	18	969 1.6×	138 0.4×	169 0.6×	223 0.9×	440 1.7×	24	1.8k
Anna De Filippis Italy	26	651 1.1×	359 1.1×	144 0.5×	223 0.9×	155 0.6×	107	2.3k
Ellen K. Wasan Canada	22	888 1.4×	268 0.8×	237 0.9×	456 1.8×	118 0.5×	50	2.8k
Wooseong Kim South Korea	28	1.2k 1.9×	145 0.4×	313 1.2×	366 1.4×	264 1.0×	98	2.6k
Qinqin Pu United States	22	1.2k 2.0×	210 0.6×	122 0.5×	264 1.0×	401 1.6×	43	2.3k
Emanuela Frangipani Italy	23	899 1.4×	145 0.4×	128 0.5×	220 0.9×	601 2.4×	54	1.8k
Anna Maria Schito Italy	25	658 1.1×	105 0.3×	250 0.9×	97 0.4×	236 0.9×	76	1.8k
Rita G. Sobral Portugal	19	526 0.8×	86 0.3×	402 1.5×	215 0.8×	226 0.9×	44	1.5k
Magdy A. Amin Egypt	26	580 0.9×	110 0.3×	164 0.6×	222 0.9×	358 1.4×	73	1.8k
Jiann‐Hwa Chen Taiwan	29	846 1.4×	229 0.7×	422 1.6×	347 1.4×	91 0.4×	95	2.5k

Countries citing papers authored by Jonathan Winkler

Since Specialization

Citations

This map shows the geographic impact of Jonathan Winkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Winkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Winkler more than expected).

Fields of papers citing papers by Jonathan Winkler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Winkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Winkler. The network helps show where Jonathan Winkler may publish in the future.

Co-authorship network of co-authors of Jonathan Winkler

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Winkler. A scholar is included among the top collaborators of Jonathan Winkler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Winkler. Jonathan Winkler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

McGovern, Barbara, Elaine Wang, Christopher B. Ford, et al.. (2021). Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection. Antimicrobial Stewardship & Healthcare Epidemiology. 1(S1). s5–s5. 1 indexed citations

Korman, Louis Y., Bret A. Lashner, Colleen S. Kraft, et al.. (2021). Fr572 24-WEEK EFFICACY AND SAFETY DATA FROM ECOSPOR-III, A PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION. Gastroenterology. 160(6). S–368. 1 indexed citations

Khanna, Sahil, Darrell S. Pardi, Colleen Kelly, et al.. (2016). A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection. The Journal of Infectious Diseases. 214(2). 173–181. 230 indexed citations

Ha, Austin Y., Patrick P. Gleason, Jonathan Winkler, et al.. (2016). Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosaassociated lymphoid tissue lymphoma treated with rituximab. PubMed. 4. 1–4. 2 indexed citations

Winkler, Jonathan, et al.. (2016). Gemella Endocarditis Presenting as an ST-Segment-Elevation Myocardial Infarction. Texas Heart Institute Journal. 43(3). 258–260. 7 indexed citations

Pandey, Shree P., Jonathan Winkler, Hu Li, et al.. (2014). Central role for RNase YbeY in Hfq-dependent and Hfq-independent small-RNA regulation in bacteria. DSpace@MIT (Massachusetts Institute of Technology).

Pandey, Shree P., Jonathan Winkler, Hu Li, et al.. (2014). Central role for RNase YbeY in Hfq-dependent and Hfq-independent small-RNA regulation in bacteria. BMC Genomics. 15(1). 121–121. 42 indexed citations

Czap, Alexandra L., Jonathan Winkler, Ilene Staff, et al.. (2013). Intracerebral Hemorrhage with Hypothyroidism. Journal of Stroke and Cerebrovascular Diseases. 22(8). e602–e609. 2 indexed citations

Winkler, Jonathan, Alexandra L. Czap, Ilene Staff, et al.. (2013). β-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage. Journal of the Neurological Sciences. 336(1-2). 127–131. 13 indexed citations

10.

Brynildsen, Mark P., et al.. (2013). Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nature Biotechnology. 31(2). 160–165. 388 indexed citations breakdown →

11.

Dwyer, Daniel J. & Jonathan Winkler. (2013). Identification and Characterization of Programmed Cell Death Markers in Bacterial Models. Methods in molecular biology. 1004. 145–159. 12 indexed citations

12.

Winkler, Jonathan, Alexandra L. Czap, Ilene Staff, et al.. (2013). Long-term Improvement in Outcome After Intracerebral Hemorrhage in Patients Treated with Statins. Journal of Stroke and Cerebrovascular Diseases. 22(8). e541–e545. 27 indexed citations

13.

Morones‐Ramírez, José Rubén, Jonathan Winkler, Catherine S. Spina, & James J. Collins. (2013). Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria. Science Translational Medicine. 5(190). 190ra81–190ra81. 615 indexed citations breakdown →

14.

Foti, James J., et al.. (2012). Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal Antibiotics. Science. 336(6079). 315–319. 4 indexed citations

15.

Davies, Bryan W., Michael A. Kohanski, Lyle A. Simmons, et al.. (2009). Hydroxyurea Induces Hydroxyl Radical-Mediated Cell Death in Escherichia coli. Molecular Cell. 36(5). 845–860. 160 indexed citations

16.

Robertson, AV, et al.. (1974). Isolation and structure confirmation of norprodigiosin from a Serratia marcescens mutant. Australian Journal of Chemistry. 27(12). 2657–2662. 8 indexed citations

17.

Archer, Alan W, et al.. (1973). Isolation of (+)-1,4-Diphenylbutane-2,3-diol from Post-Mortem Liver. Journal of the Forensic Science Society. 13(3). 191–195. 2 indexed citations

18.

Meffin, P J, A. V. Robertson, J. Thomas, & Jonathan Winkler. (1973). Neutral Metabolites of Mepivacaine in Humans. Xenobiotica. 3(3). 191–196. 7 indexed citations

19.

Still, J.L., et al.. (1972). The isolation and characterization of monopyrroles from Serratia marcescens. Biochemical and Biophysical Research Communications. 47(6). 1378–1385. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact